Alvotech ALVO
NASDAQ ALVO
$5.12 +0.09 (+1.79%)
At close: Oct 20, 2026 · 4:00 PM EDT

Alvotech (ALVO) Change in Accured Expenses (2023)

Updated

Alvotech (ALVO) reported Change in Accured Expenses of $4.67 million for FY2021, down 95.9% from $112.59 million in FY2020.

Analysis

Alvotech (ALVO) Change in Accured Expenses (2023) Analysis & Trends

  • According to Business Quant data, Change in Accured Expenses came in at $112.59 million in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn -
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 2.96 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 1.20 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn -
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn -
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 901.00 Mn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 338.00 Mn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -
10 Alvotech 1.48 Bn 1.04 Bn 2.56 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 25.20 Mn
API Access

Alvotech Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=ALVO&period=max&api_key=YOUR_API_KEY